Sign In
Buy INO
$1.14
-0.0700 (-5.79%)
At Close: Jun 03, 2026
Why Inovio Pharmaceuticals Could Be Headed For A GameStop-Like Short Squeeze
01:40pm, Thursday, 28'th Jan 2021
INO is one of the most highly shorted biotechs and among the top 25 stocks in terms of short interest listed on the NASDAQ/AMEX/NYSE. INO has recently raised funds and is planning to start a phase 3 s
3 Popular Robinhood Stocks That Could Be Better Than Bitcoin in 2021
06:04am, Thursday, 28'th Jan 2021
None of them outperformed the cryptocurrency in 2020, but that could change this year.
7 Great Cheap Stocks To Buy For Solid Growth In 2021
02:49pm, Tuesday, 26'th Jan 2021
Some of the best cheap stocks for 2021 include chipmakers like UMC stock and pharmaceuticals in the COVID-19 vaccine race such as INO stock. The post 7 Great Cheap Stocks To Buy For Solid Growth In 20
Why Editas Medicine, Inovio, Dyne, and CytomX Stocks Are Falling Today
12:00pm, Thursday, 21'st Jan 2021
All four biotechs announced the pricing of stock offerings.
Inovio's stock falls after it announces public offering
08:16am, Thursday, 21'st Jan 2021
Shares of Inovio Pharmaceuticals Inc. were down 5.1% in premarket trading on Thursday, the day after the company announced a public offering of 17,700,000 shares at $8.50 per share. The stock closed W
INOVIO Announces Pricing of Public Offering of Common Stock
10:09pm, Wednesday, 20'th Jan 2021
PLYMOUTH MEETING, Pa., Jan. 20, 2021 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and pro
INOVIO Announces Proposed Public Offering of Common Stock
04:30pm, Wednesday, 20'th Jan 2021
PLYMOUTH MEETING, Pa., Jan. 20, 2021 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and pro
Is Inovio Pharmaceuticals a Buy?
07:00am, Wednesday, 20'th Jan 2021
The biotech company's COVID-19 vaccine candidate may not be near the finish line, but that doesn't mean investors should count it out just yet.
Week In Review: China Biopharma Starts 2021 With Over $1 Billion In Deals And IPOs
03:16pm, Sunday, 10'th Jan 2021
Gracell Biotech completed a $209 million NASDAQ IPO for its next-gen CAR-T treatments. Zai Lab acquired greater China rights to an argenx SE novel treatment for autoimmune indications in a deal worth
Don't Sleep on Inovio Pharmaceuticals as a Serious Vaccine Contender
01:06pm, Monday, 04'th Jan 2021
When will INO stock finally turn a corner? That's a question on some investor's minds, and recent data suggests a turnaround might be afoot.
Inovio Strikes $100M Coronavirus Vaccine Licensing Deal With China's Advaccine
09:25am, Monday, 04'th Jan 2021
Shares of Inovio Pharmaceuticals Inc (NASDAQ: INO), which is developing a DNA vaccine against the novel coronavirus, were advancing Monday. What Happened: Plymouth Meeting, Pennsylvania-based Inovio a
Inovio to partner with Chinese biotech on COVID-19 vaccine candidate in Greater China
08:20am, Monday, 04'th Jan 2021
Shares of Inovio Pharmaceuticals Inc. were up 4.5% in premarket trading on Monday after the company announced a licensing deal with Advaccine Biopharmaceuticals Suzhou Co. Ltd. for its COVID-19 vaccin
These Were the 5 Top Genetics Stocks of 2020
06:26am, Thursday, 31'st Dec 2020
Investors in fast-moving biotechs made out like bandits.
Could Inovio Pharmaceuticals Be a Millionaire-Maker Stock?
07:02am, Wednesday, 30'th Dec 2020
This coronavirus vaccine drugmaker has already made many of its early investors rich, but its valuation is still dirt cheap.
Why Inovio Stock Sank Today
04:05pm, Monday, 28'th Dec 2020
Analysts have very different takes on the early-stage results for the company's COVID-19 vaccine candidate.
